BioinformaticsbioRxivPreprint
CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach
Jamilet Miranda, Ricardo Bringas, Jorge Fernández-de-Cossío, Yasser Perera
This study uses computational biology to investigate how CIGB-300, a CK2 kinase antagonist, may interfere with SARS-CoV-2 infection and related pathologies.
DOI 10.1101/2021.07.26.453805